“Walk In My Shoes” Highlights the Hidden Struggles of People Living with Multiple Sclerosis (MS)
Roche Pharma India partners with the Multiple Sclerosis Society of India (MSSI) for a nationwide awareness campaign
Bengaluru, August 22, 2025: Multiple Sclerosis (MS) is a chronic neurological condition that impacts millions worldwide, including nearly 200,000 people in India. The disease disrupts the central nervous system, gradually stripping away the ability to perform even the simplest tasks—such as walking, cooking, bathing, or holding a child. While the burden is heavy, it often remains unseen, making everyday life an uphill battle for those affected.
In an effort to raise awareness and build empathy, Roche Pharma India, in collaboration with the Multiple Sclerosis Society of India (MSSI), has launched Walk In My Shoes – a public health initiative aimed at shining a light on the invisible challenges faced by MS patients.
“Step Into the Shoes of MS Patients“
The campaign features #WalkInMyShoes simulation zones in major cities, offering visitors a chance to experience what living with MS feels like. Through immersive setups, participants can understand four common symptoms of the condition—loss of balance, impaired motor function, blurred vision, and loss of sensitivity.
Bengaluru: Brookfield Ecospace Park, Bellandur (August 20–22)
Mumbai: Phoenix MarketCity, Kurla (August 22–24)
New Delhi: Select City Walk Mall, Saket (August 22–24)
These experiential zones serve as platforms for “learning through experience,” helping the public understand the day-to-day struggles that remain invisible to the eye.
“Knowledge at Your Fingertips“
The campaign also introduces http://www.walkinmyshoes.in, a comprehensive online knowledge hub that provides credible, medically verified information about MS. The platform aims to empower patients, caregivers, and the public with authentic resources to support timely diagnosis, treatment, and better disease management.
Rajji Mehdwan, Managing Director & CEO – India & Neighbouring Markets, Roche Pharma emphasized, “At Roche, our responsibility extends beyond delivering medicines. Through #WalkInMyShoes, we aim to spark empathy, amplify patient voices, and inspire systemic change. Partnering with MSSI allows us to combine science with compassion to challenge stigma and foster an inclusive, patient-focused approach.”
Arun Mohan, Vice President, MSSI,said, “India’s MS ecosystem faces several challenges—from a lack of reliable prevalence data and limited insurance coverage to a shortage of specialists and absence of clear disability assessment guidelines. Early initiation of high efficacy therapies can significantly reduce the need for long-term care, easing pressure on the healthcare system. Walk In My Shoes is a strong step toward that goal.”
Dr. Pramod Krishnan, HOD, Neurology, Manipal Hospital, Bengaluru, stated, “MS treatment is entering a new era where personalized, high-efficacy therapies are replacing the one-size-fits-all approach. In India, delays in diagnosis and unequal access to care remain pressing barriers. Public health initiatives like #WalkInMyShoes are critical in raising awareness, building solidarity, and ultimately improving long-term outcomes for patients.”
City Today News 9341997936
City Today News 